APAC COVID19 Influenza A+B Antigen combo rapid test

The COVID-19/Influenza A+B Antigen Combo Rapid Screening Test is a lateral flow immunoassay test intended for the qualitative detection of SARS-CoV-2, influenza A and influenza B viral nucleocapsid protein antigens in nasal swab from individuals suspected of being infected with COVID-19 or influenza A/B within the first 5 days of symptom onset. This test is intended for self-use by persons aged 15 years or above and also for an adult testing another person under 15 years of age. Individuals over 65 years of age should consider to seek assistance in performing the test.
The test is an aid for diagnosis of COVID-19/Influenza A+B and only provides a presumptive screening test result for the SARS-CoV-2, influenza A and influenza B virus. It is intended to be used in the home or similar environment by a lay person. Confirmation of presumptive positive results is required by contacting your State or Territory Coronavirus testing services to get a laboratory PCR test. A negative result does not mean a person does not have COVID-19/Influenza A+B.